Sophie Kittler

Dr. Sophie Kittler

Tierärztliche Hochschule Hannover, 30173 Hannover, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2020 in Viruses
Verified
Journal Article
Open access
PDF file
IKImke Korf
Imke Korf
SKSophie Kittler
Sophie Kittler
ABAnna Bierbrodt
Anna Bierbrodt
RMRuth Mengden
Ruth Mengden
CRChristine Rohde
Christine Rohde
JWJohannes Wittmann
Johannes Wittmann
Worldwide, poultry industry suffers from infections caused by avian pathogenic Escherichia coli. Therapeutic failure due to resistant bacteria is of increasing concern and poses a threat to human and animal health. This causes a high demand to find alternatives to fight bacterial infections in animal farming. Bacteriophages are being especially considered for the control of multi-drug resistant bacteria due to their high specificity and lack of serious side effects. Therefore, the study aimed on characterizing phages and composing a phage cocktail suitable for the prevention of infections with E. coli. Six phages were isolated or selected from our collections and characterized individually and in combination with regard to host range, stability, reproduction, and efficacy in vitro. The cocktail consisting of six phages was able to inhibit formation of biofilms by some E. coli strains but not by all. Phage-resistant variants arose when bacterial cells were challenged with a single phage but not when challenged by a combination of four or six phages. Resistant variants arising showed changes in carbon metabolism and/or motility. Genomic comparison of wild type and phage-resistant mutant E28.G28R3 revealed a deletion of several genes putatively involved in phage adsorption and infection.

Verified
Journal Article
Open access
PDF file
FSFábia Daniela Lobo de Sá
Fábia Daniela Lobo de Sá
EBEduard Butkevych
Eduard Butkevych
Praveen Kumar NattramilarasuPraveen Kumar Nattramilarasu
Praveen Kumar Nattramilarasu
AFAnja Fromm
Anja Fromm
SMSoraya Mousavi
Soraya Mousavi
Roland BückerRoland Bücker
Roland Bücker
Campylobacter jejuni (C. jejuni) is the most common cause of foodborne gastroenteritis worldwide. The bacteria induce diarrhea and inflammation by invading the intestinal epithelium. Curcumin is a natural polyphenol from turmeric rhizome of Curcuma longa, a medical plant, and is commonly used in curry powder. The aim of this study was the investigation of the protective effects of curcumin against immune-induced epithelial barrier dysfunction in C. jejuni infection. The indirect C. jejuni-induced barrier defects and its protection by curcumin were analyzed in co-cultures with HT-29/B6-GR/MR epithelial cells together with differentiated THP-1 immune cells. Electrophysiological measurements revealed a reduction in transepithelial electrical resistance (TER) in infected co-cultures. An increase in fluorescein (332 Da) permeability in co-cultures as well as in the germ-free IL-10−/− mouse model after C. jejuni infection was shown. Curcumin treatment attenuated the C. jejuni-induced increase in fluorescein permeability in both models. Moreover, apoptosis induction, tight junction redistribution, and an increased inflammatory response—represented by TNF-α, IL-1β, and IL-6 secretion—was observed in co-cultures after infection and reversed by curcumin. In conclusion, curcumin protects against indirect C. jejuni-triggered immune-induced barrier defects and might be a therapeutic and protective agent in patients.

24 November 2021 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
GSGolshan Shakeri
Golshan Shakeri
JHJens Andre Hammerl
Jens Andre Hammerl
AJAbdollah Jamshidi
Abdollah Jamshidi
KGKiarash Ghazvini
Kiarash Ghazvini
MRManfred Rohde
Manfred Rohde
SKSophie Kittler
Sophie Kittler
Salmonella entericais one of the major global causes of foodborne enteritis in humans. The use of chemical sanitizers for reducing bacterial pathogens in the food chain can result in the spread of bacterial resistance.

10 February 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
SSSeverin Michael Steffan
Severin Michael Steffan
GSGolshan Shakeri
Golshan Shakeri
CKCorinna Kehrenberg
Corinna Kehrenberg
EPElisa Peh
Elisa Peh
MRManfred Rohde
Manfred Rohde
SKSophie Kittler
Sophie Kittler
Campylobacteriosis is a worldwide-occurring disease and has been the most commonly reported zoonotic gastrointestinal infection in the European Union in recent years. The development of successful phage-based intervention strategies will require a better understanding of phage–bacteria interactions to facilitate advances in phage cocktail design. Therefore, this study aimed to investigate the effects of newly isolated group II and group III phages and their combinations on current Campylobacter field strains. A continuous workflow for host range and efficiency of plating (EOP) value determination was combined with a qPCR-based phage group identification and a liquid-based planktonic killing assay (PKA). An advanced analysis scheme allowed us to evaluate phage cocktails by their efficacy in inhibiting bacterial population growth and the resulting phage concentrations. The results of this study indicate that data obtained from PKAs are more accurate than host range data based on plaque formation (EOP). Planktonic killing assays with Campylobacter appear to be a useful tool for a straightforward cocktail design. Results show that a group II phage vB_CcM-LmqsCP218-2c2 and group III phage vB_CjM-LmqsCP1-1 mixture would be most promising for practical applications against Campylobacter coli and Campylobacter jejuni.

16 April 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
SKSophie Kittler
Sophie Kittler
RMRuth Mengden
Ruth Mengden
IKImke Korf
Imke Korf
ABAnna Bierbrodt
Anna Bierbrodt
JWJohannes Wittmann
Johannes Wittmann
CKCorinna Kehrenberg
Corinna Kehrenberg
Among intestinal coliform microbes in the broiler gut, there are potentially pathogenic Escherichia (E.) coli that can cause avian colibacillosis. The treatment with antibiotics favors the selection of multidrug-resistant bacteria and an alternative to this treatment is urgently required. A chicken model of intestinal colonization with an apathogenic model strain of E. coli was used to test if oral phage application can prevent or reduce the gut colonization of extraintestinal pathogenic E. coli variants in two individual experiments. The E. coli strain E28 was used as a model strain, which could be differentiated from other E. coli strains colonizing the broiler gut, and was susceptible to all cocktail phages applied. In the first trial, a mixture of six phages was continuously applied via drinking water. No reduction of the model E. coli strain E28 occurred, but phage replication could be demonstrated. In the second trial, the applied mixture was limited to the four phages, which showed highest efficacy in vitro. E. coli colonization was reduced in this trial, but again, no reduction of the E. coli strain E28 was observed. The results of the trials presented here can improve the understanding of the effect of phages on single strains in the multi-strain microbiota of the chicken gut.

25 November 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
Heimesaat MarkusHeimesaat Markus
Heimesaat Markus
SMSoraya Mousavi
Soraya Mousavi
UEUlrike Escher
Ulrike Escher
FSFábia Daniela Lobo de Sá
Fábia Daniela Lobo de Sá
EPElisa Peh
Elisa Peh
SBStefan Bereswill
Stefan Bereswill
The polyphenolic compound resveratrol has been shown to exert health-beneficial properties. Given globally emerging Campylobacter infections in humans, we addressed potential anti-pathogenic, immuno-modulatory and intestinal epithelial barrier preserving properties of synthetic resveratrol in the present preclinical intervention study applying a murine acute campylobacteriosis model. Two days following peroral C. jejuni infection, secondary abiotic IL-10−/− mice were either subjected to resveratrol or placebo via the drinking water. Whereas placebo mice suffered from acute enterocolitis at day 6 post-infection, resveratrol treatment did not only lead to improved clinical conditions, but also to less pronounced colonic epithelial apoptosis as compared to placebo application. Furthermore, C. jejuni induced innate and adaptive immune cell responses were dampened in the large intestines upon resveratrol challenge and accompanied by less colonic nitric oxide secretion in the resveratrol versus the placebo cohort. Functional analyses revealed that resveratrol treatment could effectively rescue colonic epithelial barrier function in C. jejuni infected mice. Strikingly, the disease-alleviating effects of resveratrol could additionally be found in extra-intestinal and also systemic compartments at day 6 post-infection. For the first time, our current preclinical intervention study provides evidence that peroral resveratrol treatment exerts potent disease-alleviating effects during acute experimental campylobacteriosis.